Welcome to chemicalbook!
Chinese English Japanese Germany Korea
010-86108875
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List (R)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine
1037624-76-2

(R)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine synthesis

1synthesis methods
Phenyl N-cyano-N′-[(7R)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5H-benzocyclohepten-2-yl]carbamimidate

1037627-98-7
1 suppliers
inquiry

3-hydrazinyl-6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazine

802598-74-9
30 suppliers
inquiry

(R)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine

1037624-76-2
7 suppliers
inquiry

-

Yield:1037624-76-2 50%

Reaction Conditions:

in isopropyl alcohol at 90; for 18 h;

Steps:

2

SYNTHETIC EXAMPLE 2. Synthesis of 1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1 ,2-c]pyridazin-3-yl)-N3-(7-(S)-(pyrrolidin-1 -yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulene-2-yl)-1 H- 1 ,2,4-triazole-3,5- diamine and 1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1 ,2-c]pyridazin-3-yl)-N3-(7-(R)- (pyrrolidin-1 -yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulene-2-yl)-1 H- 1 ,2,4-triazole-3,5- diamine. Phenyl (S)-N'-cyano-N-(7-(pyrrolidin-1-yl)-6, 7,8, 9-tetrahydro-5H- benzo[7]annulene-2-yl)carbamimidate and phenyl (R)-N'-cyano-N-(7-(pyrrolidin-1-yl)- 6,7,8,9-tetrahydro-5H-benzo[7]annulene-2-yl)carbamimidate were treated with 3-hydrazino-6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazine in a similar manner as described above in Synthetic Example 2 to yield 1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1 ,2-c]pyridazin-3-yl)-N3-(7-(S)-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro- 5H-benzo[7]annulene-2-yl)-1H-1 ,2,4-triazole-3,5-diamine and 1-(6,7-dihydro-5H- benzo[6,7]cyclohepta[1 ,2-c]pyridazin-3-yl)-N3-(7-(R)-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro- 5H-benzo[7]annulene-2-yl)-1H-1 ,2,4-triazole-3,5-diamine . For example, a suspension of a single enantiomer of phenyl N'-cyano-N-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H- benzo[7]annulen-2-yl)carbamimidate (0.06 g, 0.16 mmol) and 3-hydrazino-6,7-dihydro- 5H-benzo[6,7]cyclohepta[1,2-c]pyridazine (0.036 g, 0.16 mmol) in 1 ml. of IPA was stirred at 90 °C for 18 h. After cooling to ambient temperature, the solvent was evaporated and the residue was purified by HPLC to provide enantiomerically pure 1- (6,7-dihydro-5H-benzo[6,7]cyclohepta[1 ,2-c]pyhdazin-3-yl)-N3-(7-(R)-(pyrrolidin-1-yl)- 6,7,8,9-tetrahydro-5H-benzo[7]annulene-2-yl)-1 H-1 ,2,4-triazole-3,5-diamine as a yellow solid (0.04 g, 50%). 1H NMR (DMSO-d6, 300 MHz) 9.11 (s, 1 H), 7.94 (s, 1 H), 7.85 (br s, 2H), 7.72 (m, 1 H), 7.46 (m, 3H), 7.37 (m, 2H), 7.06 (m, 1 H), 3.46 (m, 4H), 3.12 (m, 2H), 2.72 (m, 4H), 2.61 (m, 3H), 2.25 (m, 5H), 2.09 - 1.82 (m, 5H) ppm; MS (ES) 507 (M+H).

References:

WO2008/83367,2008,A2 Location in patent:Page/Page column 141